CRP and Lung Ultrasound in Respiratory Evaluation

Launched by FUNDACIO D'INVESTIGACIO EN ATENCIO PRIMARIA JORDI GOL I GURINA · Feb 28, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "CRP and Lung Ultrasound in Respiratory Evaluation," is looking at how well lung ultrasound (LUS) can help doctors diagnose lower respiratory tract infections (LRTIs) and decide on the best treatment. LRTIs are common illnesses that often cause symptoms like coughing and difficulty breathing, and it can be hard to tell if they are caused by a virus or bacteria. This study will check if the results from lung ultrasounds match with blood tests measuring C-Reactive Protein (CRP), which can indicate inflammation in the body. By doing this, the researchers hope to show that LUS is a quick and non-invasive tool that can help reduce unnecessary antibiotic prescriptions.

To participate in the trial, you need to be at least 18 years old, have symptoms of an LRTI lasting less than three weeks, and be able to understand and sign the consent form. However, if you've taken antibiotics in the last two weeks, have certain health conditions, or have had recent lung surgery, you won't be eligible. If you join the study, you can expect to undergo a lung ultrasound and have your CRP levels measured, which could help improve how these infections are diagnosed and treated in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years old
• • Clinical suspicion of LRTI defined as acute illness lasting less than 21 days, with cough as the main symptom, accompanied by at least one other lower respiratory symptom (such as sputum production, dyspnoea, difficult breathing, or chest pain) without any other explanation for the clinical picture.
• • Ability to read, understand and willingness to give written consent to participate in the study.
• Exclusion Criteria:
• • Patients who have been treated with antibiotics during the last 14 days up to inclusion.
• • Patients with hemodynamic instability or that need emergency medical care due to the current clinical condition.
• • Previous diagnosis of lung or pleural cancer.
• • Thoracic surgery within the past 60 days.
• • Lung interstitial diseases.
• • Patients who refuse to participate in the study